SPAS(SH:603168) 凤凰网财经·2026-03-19 13:22Core Viewpoint - The article discusses the acquisition of Shanghai Qinli Industrial Co., Ltd. by Shapais, which involves a significant premium of 24 times the net asset value, raising questions about the valuation and future performance of the acquired asset, Tianlun Hospital [2][10]. Group 1: Acquisition Details - Shapais plans to acquire 100% of Shanghai Qinli for 528 million yuan, while the net asset value of the target is only 20.97 million yuan, indicating a valuation increase of 2417.87% [2][10]. - The acquisition is part of Shapais's strategy to advance its "pharmaceutical + medical" dual-driven approach and tap into the silver economy [2][10]. Group 2: Hospital Overview - Tianlun Hospital primarily serves elderly patients within a 3 to 5 km radius, with a focus on common ailments and chronic disease management [6][7]. - The hospital is designed as a modern comprehensive facility that integrates medical, preventive, and health care services, resembling a community-based hospital [6][7]. Group 3: Market Potential - By the end of 2024, the elderly population in Hongkou District, where Tianlun Hospital is located, is projected to be 45.2%, highlighting the market potential for the silver economy [5]. - The hospital aims to increase its elderly rehabilitation bed occupancy rate from 87.2% in 2025 to 96.83% by 2031, with daily bed fees expected to rise from 570.74 yuan to 882.75 yuan [10]. Group 4: Performance Commitments and Concerns - The sellers have committed to a net profit of no less than 32.4 million yuan in 2026, 37.3 million yuan in 2027, and 42.65 million yuan in 2028, totaling at least 112 million yuan over three years [10]. - Regulatory scrutiny has increased due to past performance issues with Shapais's previous acquisitions, raising concerns about the feasibility of the optimistic profit forecasts [10][11].